Corbus Pharmaceuticals I... (CRBP)
11.99
0.54 (4.72%)
At close: Jan 15, 2025, 1:04 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Net Income | -44.60M | -42.35M | -45.64M | -111.27M | -71.45M | -55.67M | -32.42M | -20.00M | -8.85M | -2.54M | -602.35K | -886.96 |
| Depreciation & Amortization | 640.60K | 1.49M | 1.64M | 1.69M | 1.23M | 493.94K | 255.65K | 87.66K | 43.94K | 10.40K | n/a | n/a |
| Stock-Based Compensation | 3.47M | 5.72M | 9.48M | 12.46M | 11.98M | 7.61M | 5.69M | 3.16M | 1.15M | 193.12K | 6.14K | 26.26 |
| Other Working Capital | 3.07M | -3.77M | -9.74M | 264.00K | -6.46M | -4.79M | -1.94M | 88.58K | 2.04M | -95.78K | 33.48K | n/a |
| Other Non-Cash Items | 297.78K | 1.62M | 950.61K | 291.39K | 45.83K | 422.34K | 913.56K | 75.99K | -1.98K | -122.61K | 64.17K | 117.23 |
| Deferred Income Tax | n/a | n/a | 1.08M | 344.66K | n/a | 70.45K | -8.49K | 14.09K | n/a | 23.88K | n/a | n/a |
| Change in Working Capital | 4.09M | -4.02M | -15.70M | -3.20M | 12.48M | 17.01M | -2.23M | 3.09M | 3.01M | 74.46K | 165.33K | n/a |
| Operating Cash Flow | -36.10M | -37.54M | -48.18M | -99.69M | -45.72M | -30.07M | -27.80M | -13.57M | -4.65M | -2.36M | -366.71K | -769.73 |
| Capital Expenditures | n/a | -13.45K | -54.17K | -484.49K | -2.74M | -2.30M | -707.43K | -353.03K | -114.04K | -64.45K | n/a | n/a |
| Acquisitions | n/a | 8.10K | 23.90K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | -33.88M | -86.34M | -87.27M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | 69.53M | 116.42M | 13.88M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | 30.09K | -73.36K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Investing Cash Flow | 35.64M | 30.07M | -73.42M | -484.49K | -2.74M | -2.30M | -707.43K | -353.03K | -114.04K | -64.45K | n/a | n/a |
| Debt Repayment | -2.87M | -533.62K | 57.78K | 18.71M | 357.98K | 57.19K | 57.27K | 106.56K | 17.63K | n/a | 7.25K | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -190.90K | n/a | -1.82M | -6.04M | -2.57M | -690.18K | -2.94M | -63.83K | -509.21K | -1.92M | 240.00K | 1.04K |
| Financial Cash Flow | -2.82M | -533.62K | 60.82M | 154.87M | 38.46M | 11.42M | 76.01M | 16.74M | 10.84M | 8.39M | 127.25K | 1.04K |
| Net Cash Flow | -3.28M | -8.00M | -60.78M | 54.70M | -10.00M | -20.95M | 47.50M | 2.82M | 6.08M | 5.96M | -239.46K | 272.76 |
| Free Cash Flow | -36.10M | -37.56M | -48.24M | -100.17M | -48.46M | -32.37M | -28.50M | -13.92M | -4.76M | -2.43M | -366.71K | -769.73 |